Search research articles
Contact Us
Filters
Showing results (831-840 of 969) with videos related to
Page
of 97
Sort By:
Oncogene
|
June 9, 2016
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin
S Elf, R Lin, S Xia, et al.
Cancer
|
November 18, 2025
Chemotherapy alone for stage II-IVa laryngeal squamous cell carcinoma: A 20-year follow-up
Mateus Trinconi Cunha, Matheus Sewastjanow-Silva, F Christopher Holsinger, et al.
Cancer
|
May 16, 2013
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009
Benjamin Ansa, Michael Goodman, Kevin Ward, et al.
JAMA Oncology
|
December 16, 2016
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review
Conor E Steuer, Madhusmita Behera, Vinicius Ernani, et al.
Plos One
|
March 3, 2011
Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach
Yvonne J K Edwards, Gary W Beecham, William K Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
D M Shin, B S Glisson, F R Khuri, et al.
Cancer
|
March 3, 2011
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies
John Kauh, Chantal Chanel-Vos, Daniel Escuin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Modernizing Eligibility Criteria for Molecularly Driven Trials
Edward S Kim, David Bernstein, Susan G Hilsenbeck, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 14, 2004
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report
Edward S Kim, Joe B Putnam, Ritsuko Komaki, et al.
The Oncologist
|
January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis
Madhusmita Behera, Conor E Steuer, Yuan Liu, et al.
Page
of 97
Search research articles
Search
Showing results (831-840 of 969) with videos related to
Sort By:
Page
of 97
Oncogene
|
June 9, 2016
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin
S Elf, R Lin, S Xia, et al.
Cancer
|
November 18, 2025
Chemotherapy alone for stage II-IVa laryngeal squamous cell carcinoma: A 20-year follow-up
Mateus Trinconi Cunha, Matheus Sewastjanow-Silva, F Christopher Holsinger, et al.
Cancer
|
May 16, 2013
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009
Benjamin Ansa, Michael Goodman, Kevin Ward, et al.
JAMA Oncology
|
December 16, 2016
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review
Conor E Steuer, Madhusmita Behera, Vinicius Ernani, et al.
Plos One
|
March 3, 2011
Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach
Yvonne J K Edwards, Gary W Beecham, William K Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
D M Shin, B S Glisson, F R Khuri, et al.
Cancer
|
March 3, 2011
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies
John Kauh, Chantal Chanel-Vos, Daniel Escuin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Modernizing Eligibility Criteria for Molecularly Driven Trials
Edward S Kim, David Bernstein, Susan G Hilsenbeck, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 14, 2004
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report
Edward S Kim, Joe B Putnam, Ritsuko Komaki, et al.
The Oncologist
|
January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis
Madhusmita Behera, Conor E Steuer, Yuan Liu, et al.
Page
of 97